BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
79.37
-1.03 (-1.28%)
At close: Aug 26, 2026, 4:00 PM EDT
80.14
+0.77 (0.97%)
After-hours: Aug 26, 2026, 6:29 PM EDT
BridgeBio Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -691.87 | -724.93 | -535.76 | -643.2 | -481.18 | -562.54 |
Depreciation & Amortization | 5.07 | 5.43 | 6.08 | 6.49 | 6.77 | 5.84 |
Other Amortization | 6.66 | 5.97 | 7.46 | 8.91 | - | - |
Loss (Gain) From Sale of Assets | - | - | -178.32 | 1.24 | 6.26 | - |
Asset Writedown & Restructuring Costs | - | - | - | - | 12.72 | - |
Loss (Gain) From Sale of Investments | 2.3 | - | -8.14 | -18.31 | 8.22 | -29.91 |
Loss (Gain) on Equity Investments | 52.75 | 63.78 | 31.18 | - | - | - |
Stock-Based Compensation | 147.22 | 133.02 | 95.8 | 108.71 | 91.56 | 99.51 |
Other Operating Activities | 131.85 | 121.89 | 28.93 | 3.39 | -91.92 | -6.43 |
Change in Accounts Receivable | -177.62 | -134.72 | -2.97 | 15.33 | 15.17 | -19.75 |
Change in Inventory | -36.89 | -25.31 | - | - | - | - |
Change in Accounts Payable | 1.07 | 26.61 | 1.51 | 2.78 | -0.35 | 2.83 |
Change in Unearned Revenue | -9.24 | -11.43 | 21.88 | -5.44 | 15.26 | - |
Change in Other Net Operating Assets | 134.32 | 93.78 | 11.63 | -7.61 | -2 | 12.52 |
Operating Cash Flow | -434.37 | -445.91 | -520.73 | -527.72 | -419.49 | -497.93 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.02 | -1.1 | -0.93 | -1.31 | -4.82 | -13.25 |
Sale of Property, Plant & Equipment | - | - | - | - | 10 | - |
Cash Acquisitions | - | - | - | - | - | 13.65 |
Divestitures | - | - | -0.14 | -0.5 | - | - |
Sale (Purchase) of Intangibles | -2.4 | -8.5 | -7.98 | - | -1.5 | -35 |
Investment in Securities | -33.63 | -17.2 | 44.15 | 55.84 | 339.47 | -166.23 |
Other Investing Activities | 2.3 | 2.3 | 25.68 | - | 110 | - |
Investing Cash Flow | -34.74 | -24.49 | 60.78 | 54.03 | 453.15 | -200.83 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 875 | 950 | - | - | 1,204 |
Long-Term Debt Repaid | - | -459 | -473.42 | - | -20.49 | -124.12 |
Net Debt Issued (Repaid) | 601.42 | 416 | 476.58 | - | -20.49 | 1,080 |
Issuance of Common Stock | 54.51 | 34.15 | 322.9 | 459.22 | 8.08 | 20.46 |
Repurchase of Common Stock | -228.8 | -62.5 | -7.53 | -6.88 | -1.56 | -204.75 |
Other Financing Activities | -29.09 | -28.35 | -43.5 | -0.8 | 0.84 | -158.95 |
Financing Cash Flow | 398.05 | 359.29 | 748.46 | 451.54 | -13.13 | 736.45 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -71.06 | -111.1 | 288.51 | -22.15 | 20.52 | 37.69 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -435.39 | -447.01 | -521.66 | -529.03 | -424.32 | -511.18 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -61.06% | -89.03% | -235.08% | -5686.62% | -546.46% | -733.23% |
Free Cash Flow Per Share | -2.24 | -2.33 | -2.80 | -3.25 | -2.88 | -3.54 |
Levered Free Cash Flow | -320.26 | -325.29 | -291.12 | -240.16 | -285.88 | -301.13 |
Unlevered Free Cash Flow | -198.23 | -219.86 | -236.53 | -198.26 | -235.61 | -271.89 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 40.72 | 43.67 | 91.34 | 61.11 | 54.44 | 29.77 |
Cash Income Tax Paid | 1.2 | 1.2 | - | - | - | - |
Change in Working Capital | -88.35 | -51.06 | 32.04 | 5.06 | 28.08 | -4.4 |